Skip to main content
Premium Trial:

Request an Annual Quote

P-E Announces Plan to Sell Instrument Division, Names Board Member


NORWALK, Conn.--Perkin-Elmer has announced that, after a strategic review of its analytical instruments division, it will pursue selling the unit. Tony White, Perkin-Elmer's chairman, president, and CEO, said the decision was made in part to "strengthen our position as the preeminent supplier of products, information, and services to the rapidly expanding life sciences marketplace."

"With the formation of Celera Genomics and major investments in PE Biosystems, combined with the decision to sell Analytical Instruments, we have completely redefined the company," White noted. "Our objective is to accelerate the shift of genetic analysis from academia to more robust commercial applications."

In other news, the company has elected Arnold Levine, president and CEO of Rockefeller University in New York, to its board of directors. Before joining Rockefeller last year, Levine was a professor of Life Sciences at Princeton University, where he founded and guided for 12 years the molecular biology department. Previously, Levine chaired the molecular biology department at the State University of New York School of Medicine in Stony Brook. He is a member of several scientific advisory boards, including that of Perkin-Elmer's Celera Genomics business unit.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.